Early Prognostic Biomarkers of Non-Relapse Mortality in Allogeneic Mismatched Unrelated Hematopoietic Cell Transplantation

被引：0
|
作者：
Wang, Trent [1 ]
Crawford, Anna [2 ]
Fu, Denggang [3 ]
Hill, Elizabeth [3 ]
Jimenez, Antonio M. Jimenez [4 ]
Komanduri, Krishna V. [5 ]
Paczesny, Sophie [3 ]
机构：
[1] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol, Miami, FL USA
[2] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC USA
[3] Med Univ South Carolina, Charleston, SC USA
[4] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] UCSF, San Francisco, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Validation of Pre-Transplantation Plasma ST2 Levels As a Prognostic Marker of 1-Year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation
    Gjaerde, Lars Klingen
    Ostrowski, Sisse Rye
    Schierbeck, Frederikke
    Andersen, Niels Smedegaard
    Friis, Lone Smidstrup
    Kornblit, Brian Thomas
    Petersen, Soren Lykke
    Schjodt, Ida
    Sengeloev, Henrik
    BLOOD, 2021, 138
  • [32] Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality
    Mancusi, A.
    Ruggeri, L.
    Urbani, E.
    Pierini, A.
    Massei, M. S.
    Carotti, A.
    Terenzi, A.
    Falzetti, F.
    Tosti, A.
    Topini, F.
    Stern, M.
    Aversa, F.
    Martelli, M. F.
    Velardi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S150 - S150
  • [33] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Ogawa, H.
    Kurokawa, M.
    Tanaka, J.
    Kawa, K.
    Kato, K.
    Suzuki, R.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 (09) : 1198 - 1204
  • [34] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    S Kurosawa
    K Yakushijin
    T Yamaguchi
    Y Atsuta
    T Nagamura-Inoue
    H Akiyama
    S Taniguchi
    K Miyamura
    S Takahashi
    T Eto
    H Ogawa
    M Kurokawa
    J Tanaka
    K Kawa
    K Kato
    R Suzuki
    Y Morishima
    H Sakamaki
    T Fukuda
    Bone Marrow Transplantation, 2013, 48 : 1198 - 1204
  • [35] Pre- Transplant Ferritin Predicts Overall Survival and Non-Relapse Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis
    Andrade-Gonzalez, Xavier A.
    Tefferi, Ayalew
    Pardanani, Animesh
    Gangat, Naseema
    Patnaik, Mrinal M.
    Palmer, Jeanne M.
    Kharfan-Dabaja, Mohamed A.
    Litzow, Mark
    Shah, Mithun Vinod
    Hogan, William J.
    Alkhateeb, Hassan B.
    BLOOD, 2020, 136
  • [36] Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
    Inoue, Yoshitaka
    Fuji, Shigeo
    Tanosaki, Ryuji
    Ito, Reiko
    Tanaka, Takashi
    Inamoto, Yoshihiro
    Okinaka, Keiji
    Kurosawa, Saiko
    Kim, Sung-Won
    Yamashita, Takuya
    Fukuda, Takahiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S198 - S198
  • [37] Pulmonary Arterial Hypertension (PAH) Is Associated with Increased Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation (allo HCT) for Myelofibrosis
    Gupta, Rohan
    Jamal, Faizi
    Yang, Dongyun
    Ali, Haris
    Aldoss, Ibrahim
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Dobrin, Surime
    Tran, Michael
    Venkataraman, K.
    Palmer, Joycelynne
    Stein, Anthony S.
    Sandhu, Karamjeet S.
    Khaled, Samer K.
    Aribi, Ahmed
    Marcucci, Guido
    Forman, Stephen J.
    Snyder, David S.
    Nakamura, Ryotaro
    Pullarkat, Vinod
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [38] Impact of Nutrition on Non-Relapse Mortality and Acute Graft Versus Host Disease during Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
    Beckerson, Julie
    Szydlo, Richard M.
    Hickson, Mary
    Mactier, Catriona E.
    Innes, Andrew
    Gabriel, Ian H.
    Palanicawandar, Renuka
    Kanfer, Edward J.
    Macdonald, Donald
    Milojkovic, Dragana
    Rahemtulla, Amin
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    Olavarria, Eduardo
    Apperley, Jane F.
    Pavlu, Jiri
    BLOOD, 2016, 128 (22)
  • [39] Failure to Recover Thymopoiesis After Allogeneic Hematopoietic Stem Cell Transplantation Predicts for High Incidence of Opportunistic Infections and Non-Relapse Mortality
    Wils, Evert-Jan
    van der Holt, Bronno
    Broers, Annoek E. C.
    Posthumus-van Sluijs, Sandra J.
    Gratama, Jan W.
    Braakman, Eric
    Cornelissen, Jan J.
    BLOOD, 2010, 116 (21) : 362 - 363
  • [40] Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?
    Kurosawa, Saiko
    Yakushijin, Kimikazu
    Yamaguchi, Takuhiro
    Atsuta, Yoshiko
    Nagamura-Inoue, Tokiko
    Akiyama, Hideki
    Taniguchi, Shuichi
    Miyamura, Koichi
    Takahashi, Satoshi
    Eto, Tetsuya
    Morishima, Yasuo
    Sakamaki, Hisashi
    Fukuda, Takahiro
    BLOOD, 2010, 116 (21) : 397 - 397
12345